Home › Funds › Logos Global Management LP › RVMD
Logos Global Management LP position in RVMD
REVOLUTION MEDICINES INC · Health Care
Logos Global Management LP reported holding 700,000 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$131.1M, representing 5.64% of its reported portfolio and ranking #3 among its reported holdings. Logos Global Management LP has disclosed RVMD holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's RVMD position evolved
Logos Global Management LP first disclosed a stake in RVMD in Q3 2023 at 250,000 shares (US$6.9M). The position peaked in Q1 2026 at 2,000,000 shares, worth US$194.5M. Across 11 filings, Logos Global Management LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$131.1M — a reduction of -1,300,000 shares quarter over quarter.. Notable position changes include a 41% trim in Q3 2025 (shares rose 71% over the following quarter), a 100% increase in Q1 2026 (shares rose 93% over the following quarter), a 65% trim in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 250.00K | $6.92M | New |
| Q4 2023 | 350.00K | $10.04M | Add |
| Q2 2024 | 1.20M | $46.57M | New |
| Q3 2024 | 1.20M | $54.42M | Hold |
| Q4 2024 | 1.45M | $63.42M | Add |
| Q1 2025 | 1.60M | $56.58M | Add |
| Q2 2025 | 1.70M | $62.54M | Add |
| Q3 2025 | 1.00M | $46.70M | Reduce |
| Q4 2025 | 1.00M | $79.65M | Hold |
| Q1 2026 | 2.00M | $194.50M | Add |
| Q2 2026 | 700.00K | $131.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.95M sh · $551.84M · Q2 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held RVMD?
Logos Global Management LP has disclosed RVMD holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is Logos Global Management LP's current position in RVMD?
As of Q2 2026, Logos Global Management LP holds 700.00K shares of RVMD (REVOLUTION MEDICINES INC), valued at $131.10M, representing 5.64% of its reported portfolio and ranking #3.
Has Logos Global Management LP been buying or selling RVMD?
In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in RVMD. The position peaked in Q1 2026 at 2.00M shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.